Summary
IDEXX Laboratories, Inc. (IDXX) filed a Form 8-K on October 22, 2004, to report its financial results for the third quarter ended September 30, 2004. The primary purpose of this filing is to furnish the press release detailing these results, which was issued concurrently. Investors should note that this information is furnished under Item 2.02 and is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, meaning it does not carry the same liability implications as a 'filed' document. The press release itself, attached as Exhibit 99.1, contains the specific operational and financial performance data for the quarter. While the 8-K itself does not provide the detailed financial figures, it serves as the official notification and incorporation of the company's quarterly earnings announcement. Investors looking for specific performance metrics, such as revenue, earnings per share, and segmental performance, would need to refer to the referenced Exhibit 99.1 press release. The filing confirms that the company's CFO, Merilee Raines, signed off on the report, attesting to the accuracy of the information presented in the earnings release.
Key Highlights
- 1IDEXX Laboratories (IDXX) reported its Q3 2004 financial results via an 8-K filing on October 22, 2004.
- 2The filing's primary purpose is to furnish a press release (Exhibit 99.1) detailing the Q3 2004 results.
- 3The information is furnished under Item 2.02 and is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
- 4This means the disclosed results, while important, do not carry the same legal liabilities as formally 'filed' information.
- 5Investors must refer to the Exhibit 99.1 press release for the specific financial and operational details of the quarter.
- 6Merilee Raines, Vice President, Chief Financial Officer and Treasurer, signed the report.